These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes. Toth PP Postgrad Med; 2009 Jan; 121(1):59-72. PubMed ID: 19179814 [TBL] [Abstract][Full Text] [Related]
4. Prasugrel (Efient®) with percutaneous coronary intervention for treating acute coronary syndromes (review of TA182): systematic review and economic analysis. Greenhalgh J; Bagust A; Boland A; Dwan K; Beale S; Fleeman N; McEntee J; Dundar Y; Richardson M; Fisher M Health Technol Assess; 2015 Apr; 19(29):1-130. PubMed ID: 25896573 [TBL] [Abstract][Full Text] [Related]
5. Differential effects of dual antiplatelet therapy in patients presented with acute coronary syndrome vs. stable ischaemic heart disease after coronary artery bypass grafting. Choi KH; Song YB; Jeong DS; Jang YH; Hong D; Lee SY; Youn T; Bak M; Min KM; Lee JM; Park TK; Yang JH; Hahn JY; Choi JH; Choi SH; Chung SR; Cho YH; Sung K; Kim WS; Gwon HC; Lee YT Eur Heart J Cardiovasc Pharmacother; 2021 Nov; 7(6):517-526. PubMed ID: 33075126 [TBL] [Abstract][Full Text] [Related]
6. Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study. Nardin M; Verdoia M; Pergolini P; Rolla R; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G; Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):567-574. PubMed ID: 27134063 [TBL] [Abstract][Full Text] [Related]
7. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use. Reaume KT; Regal RE; Dorsch MP Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394 [TBL] [Abstract][Full Text] [Related]
9. Clopidogrel, prasugrel, or ticagrelor use and clinical outcome in patients with acute coronary syndrome: A nationwide long-term registry analysis from 2009 to 2014. Sheikh Rezaei S; Geroldinger A; Heinze G; Reichardt B; Wolzt M Int J Cardiol; 2017 May; 235():61-66. PubMed ID: 28262344 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of ticagrelor in the treatment of cardiac ischemia. Rosa GM; Bianco D; Valbusa A; Massobrio L; Chiarella F; Brunelli C Expert Opin Drug Metab Toxicol; 2016 Dec; 12(12):1491-1502. PubMed ID: 27715344 [TBL] [Abstract][Full Text] [Related]
12. Dual antiplatelet therapy with prasugrel or ticagrelor versus clopidogrel in interventional cardiology. Clemmensen P; Dridi NP; Holmvang L Cardiovasc Drugs Ther; 2013 Jun; 27(3):239-45. PubMed ID: 23380983 [TBL] [Abstract][Full Text] [Related]
13. Management of Antiplatelet Agents in Patients with History of Coronary Artery Disease in Various Medical Conditions. Shrestha A; Wilson J; Stys A S D Med; 2019 Jun; 72(6):260-266. PubMed ID: 31461231 [TBL] [Abstract][Full Text] [Related]
14. Prolonged dual antiplatelet therapy after percutaneous coronary intervention reduces ischemic events without affecting the need for repeat revascularization: insights from the CREDO trial. Brener SJ; Steinhubl SR; Berger PB; Brennan DM; Topol EJ; J Invasive Cardiol; 2007 Jul; 19(7):287-90. PubMed ID: 17620671 [TBL] [Abstract][Full Text] [Related]
15. [Antiplatelet therapy in acute coronary syndromes: state of the art and new perspectives]. Riva L; Di Pasquale G; Casella G; Calabrese D; Zagnoni S; Pallotti MG G Ital Cardiol (Rome); 2010 Dec; 11(12 Suppl 3):27S-33S. PubMed ID: 21491737 [TBL] [Abstract][Full Text] [Related]
16. Strategies to Optimize Dual Antiplatelet Therapy After Coronary Artery Stenting in Acute Coronary Syndrome. Paravattil B; Elewa H J Cardiovasc Pharmacol Ther; 2017 Jul; 22(4):347-355. PubMed ID: 28587584 [TBL] [Abstract][Full Text] [Related]
17. Unravelling the benefit against the risk of long-term dual antiplatelet therapy. Bolognese L; Angiolillo DJ Curr Opin Cardiol; 2011 Dec; 26 Suppl 1():S22-30. PubMed ID: 22129580 [TBL] [Abstract][Full Text] [Related]
19. A randomized trial to compare the safety of rivaroxaban vs aspirin in addition to either clopidogrel or ticagrelor in acute coronary syndrome: The design of the GEMINI-ACS-1 phase II study. Povsic TJ; Roe MT; Ohman EM; Steg PG; James S; Plotnikov A; Mundl H; Welsh R; Bode C; Gibson CM Am Heart J; 2016 Apr; 174():120-8. PubMed ID: 26995378 [TBL] [Abstract][Full Text] [Related]
20. Tailored antiplatelet therapy to improve prognosis in patients exhibiting clopidogrel low-response prior to percutaneous coronary intervention for stable angina or non-ST elevation acute coronary syndrome. Paarup Dridi N; Johansson PI; Lønborg JT; Clemmensen P; Radu MD; Qayyum A; Pedersen F; Kollslid R; Helqvist S; Saunamäki K; Kelbæk H; Jørgensen E; Engstrøm T; Holmvang L Platelets; 2015; 26(6):521-9. PubMed ID: 25166751 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]